MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by POWELL-JONES, W.
Right arrow Articles by LUCIER, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by POWELL-JONES, W.
Right arrow Articles by LUCIER, G. W.

Molecular Pharmacology, Vol 20, 35-42, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Binding Properties of Zearalenone Mycotoxins to Hepatic Estrogen Receptors

W. POWELL-JONES 1, S. RAEFORD 1, and G. W. LUCIER 1

1 Laboratory of Organ Function and Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709

This study investigates binding characteristics of three derivatives of the estrogenic mycotoxin zearalenone by components of liver cytosol. Studies show that cytosol from male and female rats contain similar amounts of specific estrogen receptors which sediment in the 8-9 S region of 5-20% sucrose gradients. In addition, male liver cytosol contains a second class of "nonreceptor" estrogen-binding sites sedimenting in the 4-5 S region of sucrose gradients. Sedimentation analyses show that each of the mycotoxin derivatives (P-1496, P-1502, and P-1560) behave in an analogous manner to the synthetic estrogen, diethylstilbestrol, in that they compete effectively for 8 S receptor sites, whereas they bind poorly to 4 S nonreceptor sites. The binding affinities of the derivatives for receptor sites were determined from competition studies at 4° by using partially purified receptors and a range of concentrations of the competing ligands. During a short (90-min) incubation period, the relative binding affinities of P-1496, P-1502, and P-1560 for receptor sites were 30, 17, and 12%, respectively, of that exhibited by 17beta-estradiol. The relative binding affinity of 17beta-estradiol and P-1496 did not change as a function of time at 4°. However, the relative binding affinities of P-1502 and P-1560 decreased to 6.8 and 4.2%, respectively, during an extended incubation period at 4°. The binding affinity of each derivative was similar towards partially purified liver and uterine receptors during the extended incubation period. Dissociation rate constants of 17beta-estradiol, P-1496, and P-1560 were obtained indirectly by measuring the rate of exchange of the unlabeled ligand with [3H]estradiol at 25°. The dissociation rate constants were 3.0 x 10-3 min-1, 5.6 x 10-3 min-1, and 0.14 min-1 for 17beta-estradiol, P-1496, and P-1560, respectively. These studies show that the mycotoxin derivatives have the potential for modulating liver function through interaction with specific estrogen receptors. The true estrogen potential of the derivatives may depend upon the formation of a stable slowly dissociating ligand-receptor complex.

Submitted on November 11, 1980
Accepted on February 19, 1981




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. A. McLachlan
Environmental Signaling: What Embryos and Evolution Teach Us About Endocrine Disrupting Chemicals
Endocr. Rev., June 1, 2001; 22(3): 319 - 341.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D Feldman, P. Stathis, M. Hirst, E. Stover, and Y. Do
Saccharomyces cerevisiae produces a yeast substance that exhibits estrogenic activity in mammalian systems
Science, June 8, 1984; 224(4653): 1109 - 1111.
[Abstract] [PDF]


Home page
ScienceHome page
D Feldman, Y Do, A Burshell, P Stathis, and D. Loose
An estrogen-binding protein and endogenous ligand in Saccharomyces cerevisiae: possible hormone receptor system
Science, October 15, 1982; 218(4569): 297 - 298.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics